In late 2023, the agency recommended healthcare workers stop using plastic syringes made in China-based facilities because of new dimensions, which customers said were linked to leaks and breaks. On March 19, the FDA confirmed the issue, alerting clinicians the problem is “more widespread than originally known.”
The FDA issued warnings to two distributors and one manufacturer in China for allegedly selling unauthorized syringes.
The U.S. supply of plastic syringes is sufficient without these products, so a shortage is unlikely, the agency said. Nevertheless, BD began manufacturing more syringes at its Nebraska and Connecticut facilities, the company said in a March 21 news release.
BD said the FDA’s notification does not include its syringes, but it has the capacity to meet higher demand for syringes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
